On Tuesday, Do No Harm filed an amicus brief alongside the Oklahoma Council of Public Affairs (OCPA) in defense of Oklahoma’s law prohibiting the practice of experimental gender medicine on minors. In the brief, Do No Harm and OCPA make three points: (1) the current scientific evidence reveals that the practice of experimental gender medicine on minors causes significant harm, carries serious unknown risks, and offers no proven benefit; (2) the Court should not hesitate to depart the recommendations of politically motivated medical interest groups who peddle nothing more than ideology dressed up as “science”; and (3) even if legal briefs assert that there is a supposedly “robust” and “rigorous” screening procedure for experimental gender medicine, according to public reporting, many practitioners of experimental gender medicine oppose any screening that restricts a minor’s ability to obtain puberty blockers or cross-sex hormones. A decision on the Plaintiffs’ motion for a preliminary injunction is expected in late July or August.
For the full amicus brief for Peter Poe v. Gentner Drummond, see below or click here.
Get up to speed with the threats facing healthcare – and how we’re protecting patients and physicians.
"*" indicates required fields